0001485003-20-000026.txt : 20200226 0001485003-20-000026.hdr.sgml : 20200226 20200226172113 ACCESSION NUMBER: 0001485003-20-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bourdow Carrie L. CENTRAL INDEX KEY: 0001638989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 20657212 MAIL ADDRESS: STREET 1: C/O TREVENA, INC. STREET 2: 1018 WEST 8TH AVENUE, SUITE A CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_158275565627269.xml FORM 4 X0306 4 2020-02-24 0 0001485003 Sesen Bio, Inc. SESN 0001638989 Bourdow Carrie L. C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 0 0 0 Stock Option 0.8224 2020-02-24 4 A 0 118000 0 A 2030-02-24 Common Stock 118000.0 118000 D The option was granted on February 24, 2020 and vests monthly in equal amounts over a three-year period following the grant date. /s/ Mark R. Sullivan, as attorney-in-fact 2020-02-26